Healthcare Triangle is trading 10.6% down at $1.40 today after announcing a $23.5 million deal to acquire a 51% majority stake in CosmoAesthetics Pty Ltd.
- The acquisition of the MedTech-focused firm will be funded through a combination of cash, equity, and performance-based consideration.
- The stock is extending a downward trend that began with a 4–5% drop on July 29, 2026, notably underperforming broader market indices which are currently moving higher.